Denis Drygin
No más puestos en curso
Historial de carrera de Denis Drygin
Antiguos cargos conocidos de Denis Drygin.
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| REGULUS THERAPEUTICS INC. | Director Técnico/Científico/I+D | 03/08/2020 | 29/11/2022 |
Pimera, Inc.
 Pimera, Inc. Financial ConglomeratesFinance Pimera, Inc. provides investment services. The company is headquartered in San Diego, CA. | Fundador | 01/01/2013 | 31/07/2020 |
| Corporate Officer/Principal | 01/01/2013 | 31/07/2020 | |
Cylene Pharmaceuticals, Inc.
 Cylene Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Cylene Pharmaceuticals, Inc. discovers, develops and commercializes small molecule drugs. It develops molecule drugs to treat life-threatening diseases, with a particular emphasis in oncology. The firm drug discovery platform, STAND has delivered a diverse portfolio of drug candidates that target the multiple pathways critical for the support, maintenance of cancer cells and that address unmet medical needs with substantial markets. The company was founded in 1997 by Thomas James Farrell and Daniel Douglas Von Hoff and is headquartered in San Diego, CA. | Corporate Officer/Principal | - | - |
Formación de Denis Drygin.
| University of Massachusetts | Doctorate Degree |
| Moscow State University Lomonosov | Graduate Degree |
Estadísticas
Internacional
| Estados Unidos | 5 |
| Rusia | 2 |
Operativa
| Corporate Officer/Principal | 2 |
| Graduate Degree | 2 |
| Chief Tech/Sci/R&D Officer | 1 |
Sectorial
| Health Technology | 3 |
| Consumer Services | 3 |
| Finance | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| REGULUS THERAPEUTICS INC. | Health Technology |
| Empresas privadas | 2 |
|---|---|
Pimera, Inc.
Pimera, Inc. Financial ConglomeratesFinance Pimera, Inc. provides investment services. The company is headquartered in San Diego, CA. | Finance |
Cylene Pharmaceuticals, Inc.
Cylene Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Cylene Pharmaceuticals, Inc. discovers, develops and commercializes small molecule drugs. It develops molecule drugs to treat life-threatening diseases, with a particular emphasis in oncology. The firm drug discovery platform, STAND has delivered a diverse portfolio of drug candidates that target the multiple pathways critical for the support, maintenance of cancer cells and that address unmet medical needs with substantial markets. The company was founded in 1997 by Thomas James Farrell and Daniel Douglas Von Hoff and is headquartered in San Diego, CA. | Health Technology |
- Bolsa de valores
- Insiders
- Denis Drygin
- Experiencia
